Previous Article | Next Article 
Journal of Virology, September 1999, p. 7262-7270, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
RhoA Interacts with the Fusion Glycoprotein of
Respiratory Syncytial Virus and Facilitates Virus-Induced
Syncytium Formation
Manoj K.
Pastey,1
James E.
Crowe Jr.,2,3 and
Barney S.
Graham1,2,*
Departments of
Medicine,1 Microbiology & Immunology,2 and
Pediatrics,3 Vanderbilt University
School of Medicine, Nashville, Tennessee 37232
Received 8 April 1999/Accepted 8 June 1999
The fusion glycoprotein (F) of respiratory syncytial virus (RSV),
which mediates membrane fusion and virus entry, was shown to bind RhoA,
a small GTPase, in yeast two-hybrid interaction studies. The
interaction was confirmed in vivo by mammalian two-hybrid assay and in
RSV-infected HEp-2 cells by coimmunoprecipitation. Furthermore, the
interaction of F with RhoA was confirmed in vitro by enzyme-linked
immunosorbent assay and biomolecular interaction analysis. Yeast
two-hybrid interaction studies with various deletion mutants of F and
with RhoA indicate that the key binding domains of these proteins are
contained within, or overlap, amino acids 146 to 155 and 67 to 110, respectively. The biological significance of this interaction was
studied in RSV-infected HEp-2 cells that were stably transfected to
overexpress RhoA. There was a positive correlation between RhoA
expression and RSV syncytium formation, indicating that RhoA can
facilitate RSV-induced syncytium formation.
*
Corresponding author. Mailing address: A-4103 MCN,
Vanderbilt University School of Medicine, 1161 21st Ave. South,
Nashville, TN 37232-2582. Phone: (615) 343-3717. Fax: (615)
322-8222. E-mail: Barney.Graham{at}mcmail.vanderbilt.edu.
Journal of Virology, September 1999, p. 7262-7270, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Batonick, M., Oomens, A. G. P., Wertz, G. W.
(2008). Human Respiratory Syncytial Virus Glycoproteins Are Not Required for Apical Targeting and Release from Polarized Epithelial Cells. J. Virol.
82: 8664-8672
[Abstract]
[Full Text]
-
Eckardt-Michel, J., Lorek, M., Baxmann, D., Grunwald, T., Keil, G. M., Zimmer, G.
(2008). The Fusion Protein of Respiratory Syncytial Virus Triggers p53-Dependent Apoptosis. J. Virol.
82: 3236-3249
[Abstract]
[Full Text]
-
Fernandes, L. B., Henry, P. J., Goldie, R. G.
(2007). Review: Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease. Ther Adv Respir Dis
1: 25-33
[Abstract]
-
Crim, R. L., Audet, S. A., Feldman, S. A., Mostowski, H. S., Beeler, J. A.
(2007). Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity. J. Virol.
81: 261-271
[Abstract]
[Full Text]
-
Oomens, A. G. P., Wertz, G. W.
(2004). trans-Complementation Allows Recovery of Human Respiratory Syncytial Viruses That Are Infectious but Deficient in Cell-to-Cell Transmission. J. Virol.
78: 9064-9072
[Abstract]
[Full Text]
-
Budge, P. J., Graham, B. S.
(2004). Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. J Antimicrob Chemother
54: 299-302
[Abstract]
[Full Text]
-
Budge, P. J., Li, Y., Beeler, J. A., Graham, B. S.
(2004). RhoA-Derived Peptide Dimers Share Mechanistic Properties with Other Polyanionic Inhibitors of Respiratory Syncytial Virus (RSV), Including Disruption of Viral Attachment and Dependence on RSV G. J. Virol.
78: 5015-5022
[Abstract]
[Full Text]
-
Easton, A. J., Domachowske, J. B., Rosenberg, H. F.
(2004). Animal Pneumoviruses: Molecular Genetics and Pathogenesis. Clin. Microbiol. Rev.
17: 390-412
[Abstract]
[Full Text]
-
Budge, P. J., Lebowitz, J., Graham, B. S.
(2003). Antiviral Activity of RhoA-Derived Peptides against Respiratory Syncytial Virus Is Dependent on Formation of Peptide Dimers. Antimicrob. Agents Chemother.
47: 3470-3477
[Abstract]
[Full Text]
-
McCurdy, L. H., Graham, B. S.
(2003). Role of Plasma Membrane Lipid Microdomains in Respiratory Syncytial Virus Filament Formation. J. Virol.
77: 1747-1756
[Abstract]
[Full Text]
-
Hashimoto, K, Peebles, R S Jr, Sheller, J R, Jarzecka, K, Furlong, J, Mitchell, D B, Hartert, T V, Graham, B S
(2002). Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax
57: 524-527
[Abstract]
[Full Text]
-
Brown, G., Aitken, J., Rixon, H. W. McL., Sugrue, R. J.
(2002). Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol.
83: 611-621
[Abstract]
[Full Text]
-
McNamara, P. S, Smyth, R. L
(2002). The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull
61: 13-28
[Abstract]
[Full Text]
-
Gower, T. L., Graham, B. S.
(2001). Antiviral Activity of Lovastatin against Respiratory Syncytial Virus In Vivo and In Vitro. Antimicrob. Agents Chemother.
45: 1231-1237
[Abstract]
[Full Text]
-
Feldman, S. A., Audet, S., Beeler, J. A.
(2000). The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate. J. Virol.
74: 6442-6447
[Abstract]
[Full Text]